Open AccessA Neuroendocrine Tumor Specialty Center in New Orleans’ ( NOLANETS ) Response to Patient Care During the COVID ‐19 Pandemic
Author(s) -
Ramirez Robert A.,
BrenMattison Yvette,
Thiagarajan Ramcharan,
Boudreaux J. Philip,
Marsala Andrew J.,
Ryan Pamela,
Maluccio Mary A.
Publication year - 2020
Publication title -
the oncologist
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.176
H-Index - 164
eISSN - 1549-490X
pISSN - 1083-7159
DOI - 10.1634/theoncologist.2020-0279
Subject(s) - medicine , pandemic , covid-19 , specialty , center (category theory) , patient care , medical emergency , intensive care medicine , family medicine , virology , nursing , disease , infectious disease (medical specialty) , chemistry , outbreak , crystallography
This commentary outlines the steps taken by the New Orleans Louisiana Neuroendocrine Tumor Specialists to minimize the risk of patient exposure to SARS‐CoV‐2 but to continue to provide safe, high‐quality care during the COVID‐19 pandemic.